Executive Park Jun-hyun Increases Stake by 1,000 Shares Through Exercise of Stock Purchase Rights (3,000 shares at 18,050 won) and Open Market Sale (2,000 shares at 167,300 won), Ownership Rises from 0.03% to 0.04%


  • Executive Park Jun-hyun exercised stock purchase rights on May 26, 2026, acquiring 3,000 common shares at 18,050 won each, and sold 2,000 shares on the open market on May 28, 2026 at 167,300 won each, resulting in a net increase of 1,000 shares.
  • The exercise of stock purchase rights is a benefit granted to executives, allowing acquisition at a price significantly below market value, facilitating profit-taking; the subsequent sale appears aimed at realizing short-term gains.
  • This transaction increased his stake from 0.03% to 0.04%, a negligible change relative to total outstanding shares of 22,301,830, with no direct impact on shareholder value. While insider selling may dampen sentiment, the exercise itself could be interpreted as confidence in the company's growth.
  • [AI Summary]This is a routine disclosure of minor insider trading with limited market impact. The low-price exercise followed by a high-price sale represents personal profit-taking and does not affect the company's fundamentals.

KOSDAQ Filing Information


  • Filing: Report on Ownership of Specific Securities by Executives and Major Shareholders
  • Company: OliX Pharmaceuticals (226950)
  • Submission: Park Jun-hyun
  • Receipt: 06-01-2026